X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA BIOCON LTD ELDER PHARMA/
BIOCON LTD
 
P/E (TTM) x -0.2 70.3 - View Chart
P/BV x 0.1 6.6 1.5% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ELDER PHARMA   BIOCON LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
BIOCON LTD
Mar-17
ELDER PHARMA/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs3801,162 32.7%   
Low Rs188483 39.0%   
Sales per share (Unadj.) Rs491.2194.6 252.5%  
Earnings per share (Unadj.) Rs-3.234.4 -9.2%  
Cash flow per share (Unadj.) Rs14.448.3 29.9%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs376.5241.9 155.7%  
Shares outstanding (eoy) m20.54200.00 10.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.64.2 13.7%   
Avg P/E ratio x-89.323.9 -373.5%  
P/CF ratio (eoy) x19.717.0 115.7%  
Price / Book Value ratio x0.83.4 22.2%  
Dividend payout %02.9 0.0%   
Avg Mkt Cap Rs m5,833164,440 3.5%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m2,1797,470 29.2%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m10,08938,911 25.9%  
Other income Rs m2571,571 16.3%   
Total revenues Rs m10,34640,482 25.6%   
Gross profit Rs m-7929,795 -8.1%  
Depreciation Rs m3612,772 13.0%   
Interest Rs m2,756260 1,060.1%   
Profit before tax Rs m-3,6538,334 -43.8%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,616 7.7%   
Profit after tax Rs m-656,881 -0.9%  
Gross profit margin %-7.825.2 -31.2%  
Effective tax rate %-3.419.4 -17.7%   
Net profit margin %-0.617.7 -3.7%  
BALANCE SHEET DATA
Current assets Rs m9,24040,477 22.8%   
Current liabilities Rs m9,99816,783 59.6%   
Net working cap to sales %-7.560.9 -12.3%  
Current ratio x0.92.4 38.3%  
Inventory Days Days4660 77.7%  
Debtors Days Days6083 72.3%  
Net fixed assets Rs m10,12445,073 22.5%   
Share capital Rs m2061,000 20.6%   
"Free" reserves Rs m5,58247,377 11.8%   
Net worth Rs m7,73448,377 16.0%   
Long term debt Rs m4,88921,082 23.2%   
Total assets Rs m22,88293,942 24.4%  
Interest coverage x-0.333.1 -1.0%   
Debt to equity ratio x0.60.4 145.1%  
Sales to assets ratio x0.40.4 106.4%   
Return on assets %11.87.6 154.7%  
Return on equity %-0.814.2 -5.9%  
Return on capital %22.312.6 177.0%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30712,988 2.4%   
Fx outflow Rs m1257,899 1.6%   
Net fx Rs m1815,089 3.6%   
CASH FLOW
From Operations Rs m11,7546,400 183.7%  
From Investments Rs m-561-4,985 11.2%  
From Financial Activity Rs m-6,762-1,775 380.9%  
Net Cashflow Rs m4,432-473 -936.9%  

Share Holding

Indian Promoters % 39.6 40.4 98.0%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 7.5 8.4 89.3%  
FIIs % 16.8 10.7 157.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 19.9 181.4%  
Shareholders   16,479 109,995 15.0%  
Pledged promoter(s) holding % 77.6 0.0 193,900.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS